Go Deep
EnBio Holdings, Inc
EnBio Holdings, Inc Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,759 | 11.3 | 0.66 | 1.09 | 469.16 |
| Oct 2026 | 22,847 | 11.3 | 0.66 | 1.09 | 468.26 |
| Oct 2026 | 22,795 | 11.3 | 0.67 | 1.09 | 473.20 |
| Oct 2026 | 22,820 | 11.5 | 0.67 | 1.09 | 470.69 |
EnBio Holdings, Inc Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,841,000,000.0 | 3,528,000,000.0 | 3,419,000,000.0 | 3,245,000,000.0 |
| Net Profit | 298,000,000.0 | 330,000,000.0 | -608,000,000.0 | 534,000,000.0 |
| EPS | 36.7 | — | — | — |
EnBio Holdings, Inc Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 12,630,000,000.0 | 10,668,000,000.0 | 9,575,536,000.0 | 8,120,309,000.0 |
| Net Profit | 265,000,000.0 | 452,000,000.0 | 708,764,000.0 | 812,059,000.0 |
| EPS | 32.7 | 55.9 | 88.8 | 122.3 |
EnBio Holdings, Inc Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 22,848,000,000.0 | 21,195,000,000.0 | 19,310,518,000.0 | 17,349,955,000.0 | — |
| Total Liabilities | 13,524,000,000.0 | 11,966,000,000.0 | 10,718,909,000.0 | 10,492,714,000.0 | — |
| Total Equity | 9,246,000,000.0 | 9,140,000,000.0 | 8,494,704,000.0 | 6,788,007,000.0 | — |
Owes vs Owns
EnBio Holdings, Inc owed ¥0.57 for every ¥1 it owned in Jun 2026, down from ¥0.60 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.57× | 0.59× | 0.56× | 0.56× | 0.60× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
EnBio Holdings, Inc Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 17.7%Receivables 10.1%Inventory 19.5%Fixed assets (tangible) 38.4%Intangible assets 1.8%Long-term investments 1.6%Other assets 11.0%
How it's funded — Mar 2026
Short-term debt 12.6%Long-term debt 34.0%Payables 5.1%Other liabilities 7.5%Shareholders' equity 40.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4,036.0 | 3,293.0 | 3,604.1 | 2,828.7 |
| Receivables | 2,309.0 | 2,354.0 | 1,281.9 | 806.4 |
| Inventory | 4,445.0 | 2,952.0 | 2,889.2 | 3,373.2 |
| Fixed assets (tangible) | 8,771.0 | 8,827.0 | 7,918.3 | 7,016.6 |
| Intangible assets | 417.0 | 445.0 | 475.7 | 509.5 |
| Long-term investments | 368.0 | 836.0 | 651.9 | 585.4 |
| Other assets | 2,502.0 | 2,488.0 | 2,489.4 | 2,230.1 |
| Liabilities & equity | ||||
| Short-term debt | 2,887.0 | 3,454.0 | 2,389.5 | 3,147.7 |
| Long-term debt | 7,766.0 | 6,643.0 | 6,230.7 | 5,749.3 |
| Payables | 1,161.0 | 744.0 | 937.7 | 400.6 |
| Other liabilities | 1,710.0 | 1,125.0 | 1,161.0 | 1,195.2 |
| Shareholders' equity | 9,324.0 | 9,229.0 | 8,591.6 | 6,857.2 |
| Net tangible assets | 8,829.0 | 8,695.0 | 8,019.0 | 6,278.5 |
EnBio Holdings, Inc Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 1,167,000,000.0 | 21,000,000.0 | 1,663,431,000.0 | 1,989,080,000.0 | — |
| Investing Activities | -895,000,000.0 | -1,602,000,000.0 | -1,583,696,000.0 | -1,770,420,000.0 | — |
| Financing Activities | 464,000,000.0 | 1,274,000,000.0 | 638,922,000.0 | 240,727,000.0 | — |